CYP19A1 and neoplasm: Estrogen receptor (ER) positive breast cancer patients are treated routinely with surgical tumor resection, local radiation, and chemotherapy depending on stage and tumor subtype, followed by adjuvant hormonal therapy, either tamoxifen or an aromatase-inhibitor, for at least 5 years [1].